课题基金 / 基金详情

Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial

Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial
肝素抗凝可改善感染性休克的预后:HALO 国际 II 期试验
批准号:
357706
负责人:
Zarychanski Ryan
金额:
$45.98万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2019-10-01

项目摘要

项目成果

Zarychanski Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
危及生命的感染占所有重症监护病房入院人数的10%,是重症监护病房中仅次于心脏病的第二大常见死亡原因。感染危及生命的病人最常见的死亡原因
英文摘要
Life-threatening infections account for 10% of all intensive care unit admissions and constitute the second more frequent cause of death in the ICU after heart diseases. The most common cause of death in patients admitted with life-threatening infections
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)
  • 批准号:
    463407
  • 项目类别:
    Operating Grants
  • 资助金额:
    $288.63万
  • 财政年份:
    2022
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
  • 批准号:
    429655
  • 项目类别:
    Operating Grants
  • 资助金额:
    $260.32万
  • 财政年份:
    2020
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
  • 批准号:
    405787
  • 项目类别:
    Operating Grants
  • 资助金额:
    $174.34万
  • 财政年份:
    2019
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Tranexamic acid to reduce red blood cell transfusion in major non-cardiac surgery (TRACTION): A pragmatic, registry-based, pilot, randomized controlled trial
  • 批准号:
    398808
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
海外基金